Mayo Clinic Talks
View all posts »#11: Controversies in ICD implantation
Jul 25, 2012 16:00 EDT-
1Comments
-
Read later
Despite a significant body of trial data supporting the implantation of ICDs for secondary and primary prevention, controversies persist. Dr Paul Friedman joins Dr Bernard Gersh to discuss the issues that cloud patient selection and how to cope with ICD lead malfunction. They also review the future of subcutaneous lead-based ICD systems and how devices will be improved by new designs and technology.
See also:
- Nearly a quarter of ICD implants are not recommended by professional guidelines
- Riata revelations: ICD lead failure rates, mechanisms take HRS center stage
- Trials and Fibrillations with Dr John Mandrola
Dr Friedman has received research support from Medtronic (grant administered by Mayo Clinic for investigator-initiated study). He has served as a speaker at an educational event that received industry support from St Jude and Biotronik.
Dr Gersh has no relevant financial disclosures.
 |
 |
 |
||
 |
|
 |
||
 |
 |
 |
||
 |
|
|
 |
|
 |
 |
 |
||
 |
|
|
 |
|
|
|
|
||
|
||||
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!
